Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somer...

FDA Recall #D-0367-2025 — Class II — April 2, 2025

Recall #D-0367-2025 Date: April 2, 2025 Classification: Class II Status: Ongoing

Product Description

Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala, Bangalore - 562123, Karnataka, India, Manufactured for: BluePoint Laboratories, NDC 68001-580-41.

Reason for Recall

Lack of assurance of sterility. Bacterial contamination detected in some media fill units

Recalling Firm

Amerisource Health Services LLC — Columbus, OH

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

2,110 vials

Distribution

Nationwide in the USA

Code Information

A240467B, EXP 07/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated